Financial Performance - The company recorded no revenue for the six months ended June 30, 2021, compared to HKD 72 million in the same period of 2020, with a consolidated loss attributable to owners of HKD 99 million, down from HKD 314 million in 2020 [5]. - For the six months ended June 30, 2021, the company reported a total revenue of HKD 0, compared to HKD 7,173,000 for the same period in 2020, representing a decline of 100% [26]. - The company recorded a gross profit of HKD 0, down from HKD 3,894,000 in the previous year, reflecting a complete halt in revenue generation [26]. - The company reported a loss before tax of HKD (9,942,000), an improvement from a loss of HKD (31,444,000) in the prior year, indicating a reduction in losses by approximately 68% [26]. - The total comprehensive loss for the period was HKD (9,942,000), compared to HKD (31,443,000) in the previous year, marking a significant decrease in overall losses [26]. - The company recorded a net loss of HKD 9,942,000 for the six months ended June 30, 2021, compared to a loss of HKD 29,860,000 in the same period of 2020, indicating a significant improvement [36]. - The company reported a total cash outflow from operating activities of HKD 1,723,000 for the six months ended June 30, 2021, an improvement from HKD 3,945,000 in the previous year [33]. Assets and Liabilities - Total assets and net liabilities as of June 30, 2021, were HKD 127 million and HKD 316.8 million, respectively, compared to HKD 273 million and HKD 316.3 million as of December 31, 2020 [6]. - As of June 30, 2021, total assets were HKD 10,874,000, down from HKD 19,022,000 at the end of 2020, reflecting a decline of approximately 43% [28]. - The company's total liabilities increased to HKD 316,836,000 from HKD 316,303,000, indicating a slight increase in financial obligations [28]. - The total liabilities as of June 30, 2021, amounted to HKD 316,800,000, with current liabilities at HKD 234,400,000 [36]. - The company has a total equity attributable to owners of HKD (301,017,000) as of June 30, 2021, reflecting a decrease from the previous period [36]. - The company recorded a total asset value of HKD 12,743,000 as of June 30, 2021, compared to HKD 27,297,000 as of December 31, 2020, indicating a decrease in total assets [42]. - The company reported a total liability of HKD 329,579,000 as of June 30, 2021, compared to HKD 343,600,000 as of December 31, 2020, reflecting a reduction in total liabilities [42]. Cash and Financing - The company's cash and bank balances were HKD 4 million as of June 30, 2021, down from HKD 11 million as of December 31, 2020, with a current ratio of 0.04 compared to 0.08 in the previous period [6]. - Cash and cash equivalents decreased to HKD 372,000 at the end of June 2021, down from HKD 2,191,000 at the end of June 2020 [33]. - The company has obtained financing of HKD 8,000,000 and HKD 12,000,000 from investors to support its operational costs and business activities [37]. - Interest expenses for the six months ended June 30, 2021, decreased to HKD 8,236,000 from HKD 9,968,000 in the same period of 2020, showing a reduction in financing costs [46]. - The company's borrowings increased to HKD 205,054,000 as of June 30, 2021, from HKD 201,630,000 as of December 31, 2020, reflecting a slight increase in debt levels [52]. Operational Activities - The company has been actively seeking business opportunities to enhance long-term shareholder value despite challenges from the COVID-19 pandemic and other geopolitical factors [7]. - No significant capital raising activities were conducted during the six months ended June 30, 2021 [8]. - There were no major investments, acquisitions, or disposals during the reporting period [9]. - The company has no significant assets pledged as collateral as of June 30, 2021 [10]. - The total number of employees as of June 30, 2021, was 4, with compensation based on performance and market levels [14]. - The company remains committed to strict financial management and is exploring new business opportunities for profit growth and stakeholder value enhancement [7]. - The company faced a liquidation of a subsidiary in March 2021, which was finalized in July 2021, impacting its operational structure [55]. Segment Performance - The medical and health business segment reported no revenue for the six months ended June 30, 2021, compared to HKD 7,173,000 in the same period of 2020 [38]. - The company has not reported any segment revenue for its medical and health lifestyle business for the current period [40]. - The company is focusing on developing its medical and health lifestyle business to improve cash flow [37]. Expenses and Income - The cost of goods sold and services for the same period was HKD (0), while it was HKD (3,279,000) in 2020, indicating a significant reduction in operational costs [26]. - Other income, gains, and losses increased to HKD 9,127,000 from HKD 2,992,000, showing a growth of approximately 205% [26]. - Administrative expenses decreased to HKD (10,833,000) from HKD (22,590,000), a reduction of about 52% [26]. - The company had no share options or share awards granted during the six months ended June 30, 2021, maintaining a status quo in equity compensation plans [20][21]. - The company has no interim dividend declared for the six months ended June 30, 2021, consistent with the previous year [48].

Financial Performance - The company recorded revenue of HKD 9.6 million for the year ended December 31, 2020, a decrease of 76.1% from HKD 40.2 million in 2019[5]. - Gross profit was HKD 5.2 million, down 77.7% from HKD 23.3 million in 2019, with a gross margin of 54.3% compared to 58.0% in the previous year[5]. - The consolidated loss attributable to the company's owners was HKD 50.8 million, an improvement from HKD 77.0 million in 2019[5]. - The company reported a loss before tax of HKD 52,470,000, an improvement from a loss of HKD 79,217,000 in the previous year, indicating a 34% reduction in losses[118]. - The company recorded a net loss attributable to owners of the company of HKD 50,846,000 for 2020, compared to HKD 76,984,000 in 2019, representing a 34% improvement[125]. - The company’s total comprehensive loss for the year was HKD 52,470,000, down from HKD 168,729,000 in 2019, indicating a 69% reduction[118]. - The basic and diluted loss per share for 2020 was HKD 0.156, an improvement from HKD 0.236 in 2019[118]. Assets and Liabilities - Total assets amounted to HKD 27.3 million, down from HKD 41.7 million in 2019, while total liabilities increased to HKD 316.3 million from HKD 263.8 million[6]. - As of December 31, 2020, the group's current liabilities and total liabilities were HKD 183.5 million and HKD 316.3 million, respectively, including borrowings of HKD 118.5 million due within one year[112]. - The group's cash and cash equivalents balance was HKD 1.1 million, indicating insufficient cash to immediately repay borrowings[112]. - Non-current liabilities increased to HKD 141,030,000 in 2020 from HKD 107,375,000 in 2019, reflecting a rise of 31%[120]. Cash Flow and Financing - Cash flow from operating activities showed a net outflow of HKD 9,869,000 in 2020, an improvement from HKD 16,180,000 in 2019[125]. - The company raised new loans totaling HKD 12,518,000 in 2020, compared to HKD 45,343,000 in 2019, indicating a decrease in financing activity[125]. - The company has obtained a loan of HKD 8,000,000 to cover operational costs and an additional loan of HKD 12,000,000 to support business operations[142]. Business Strategy and Opportunities - The company is actively seeking business opportunities to enhance long-term shareholder value despite challenges from COVID-19 and other geopolitical factors[19]. - The company plans to expand its medical equipment and product distribution business, which showed good progress in 2022[19]. - The company aims to implement prudent financial management policies to improve cash flow and seek profitable growth opportunities[19]. Governance and Compliance - The board acknowledges ongoing risks, including competition and credit risk, which may impact financial performance[15][16]. - The company has complied with all code provisions of the corporate governance code during the year ended December 31, 2020, except for the non-executive directors having no fixed term[68]. - The audit committee is composed entirely of independent non-executive directors and has reviewed the accounting principles and practices adopted by the group[62]. - The board confirmed adherence to the standards for securities trading as per the listing rules for the year ended December 31, 2020[83]. Environmental and Social Responsibility - The company operates without generating air pollutants or regulated emissions, indicating a commitment to reducing environmental impact[90]. - The company does not produce hazardous waste and has implemented policies to minimize waste generation and improve resource efficiency[91]. - The company encourages resource-efficient practices, such as recycling and reducing unnecessary business travel, to lower greenhouse gas emissions[92]. - The company is committed to providing a safe and equitable work environment, adhering to various employment laws and regulations[97]. - The company has implemented health and safety measures in response to the COVID-19 pandemic, ensuring employee well-being[98]. Employee and Management Information - The group had 5 employees as of December 31, 2020, a decrease from 62 in 2019[61]. - The company is in the process of identifying a suitable candidate for the CEO position following the vacancy during the year[70]. - The board held four meetings during the year, with all directors in attendance[75]. Audit and Financial Reporting - The independent auditor was unable to obtain sufficient appropriate audit evidence regarding the financial statements due to limitations in the audit scope[106]. - The financial statements are prepared based on the historical cost basis, except for certain financial instruments measured at fair value[134]. - The group has taken reasonable measures to locate specific records for audit purposes, but sufficient appropriate audit evidence could not be obtained[136]. Revenue Recognition and Accounting Policies - Revenue is recognized when control of goods or services is transferred to customers, reflecting the expected consideration to be received, excluding VAT or other sales taxes[168]. - The company recognizes an asset from contract costs when they meet specific criteria, with subsequent amortization aligned with the transfer of goods or services to customers[173]. - Financial assets are initially measured at fair value plus transaction costs, except for trade receivables without significant financing components, which are measured at transaction price[151].

Financial Performance - The company recorded revenue of HKD 7.2 million for the six months ended June 30, 2020, down from HKD 23.9 million in 2019, representing a decline of approximately 69.9%[5] - Gross profit was HKD 3.9 million with a gross margin of 54.3%, compared to HKD 12.6 million and a gross margin of 52.8% in 2019[5] - The company reported a consolidated loss of HKD 31.4 million, an increase from HKD 25.0 million in the previous year, indicating a rise in losses of approximately 25.6%[5] - For the six months ended June 30, 2020, the company reported revenue of HKD 7,173,000, a decrease of 70% compared to HKD 23,911,000 for the same period in 2019[26] - The gross profit for the same period was HKD 3,894,000, down 69% from HKD 12,617,000 in 2019[26] - The company incurred a loss before tax of HKD 31,443,000, compared to a loss of HKD 24,974,000 in the previous year, representing a 26% increase in losses[26] - The total comprehensive loss for the period was HKD 31,443,000, compared to HKD 25,406,000 in 2019, indicating a 24% increase in total losses[26] - The company reported a net loss of HKD 31,400,000 for the six months ended June 30, 2020[38] - The company reported a total loss of HKD 31,443,000 for the six months ended June 30, 2020, compared to a loss of HKD 24,974,000 for the same period in 2019, representing a 26% increase in losses[42][43] Assets and Liabilities - Total assets and net liabilities as of June 30, 2020, were HKD 30.7 million and HKD 295.3 million, respectively, compared to HKD 41.7 million and HKD 263.8 million at the end of 2019[6] - As of June 30, 2020, the company's total assets were HKD 21,495,000, down from HKD 25,249,000 at the end of 2019[28] - The company's current liabilities increased to HKD 219,851,000 from HKD 198,169,000 at the end of 2019, reflecting an increase of 11%[28] - The net liabilities of the company stood at HKD 295,276,000 as of June 30, 2020, compared to HKD 263,833,000 at the end of 2019, marking a 12% increase[28] - The total liabilities increased to HKD 325,944,000 as of June 30, 2020, compared to HKD 305,544,000 as of December 31, 2019[44] Cash Flow and Financing - The company’s cash and bank balance decreased to HKD 2.2 million from HKD 3.4 million at the end of 2019[6] - The cash used in operating activities was HKD 3,945,000 for the six months ended June 30, 2020, compared to HKD 13,039,000 for the same period in 2019[35] - The company reported a decrease in cash and cash equivalents of HKD 1,164,000 for the six months ended June 30, 2020[35] - The company’s cash and cash equivalents at the end of the period were HKD 2,191,000, down from HKD 3,182,000 at the end of the previous year[35] - The company received a loan of HKD 8,000,000 from an investor to cover operational costs and an additional loan of HKD 12,000,000 to support business operations[39] - The company believes it has sufficient working capital to meet its financial obligations for the next twelve months[38] Corporate Governance and Future Outlook - The company remains committed to maintaining high standards of corporate governance and has complied with the relevant codes during the reporting period[23] - The company is optimistic about the future growth of its medical equipment and product distribution business, despite challenges from global economic conditions[7] - The company aims to seek new business opportunities to achieve profit growth and enhance long-term stakeholder value[7] - The company is actively developing its healthcare and wellness business to improve operational cash flow[39] Share Options and Dividends - The company did not grant any share options or share awards during the six months ended June 30, 2020[20][26] - The company has adopted a share option scheme and a share award scheme to incentivize eligible participants, but no options or awards were granted in the reporting period[20][26] - The company did not declare an interim dividend for the six months ended June 30, 2020, consistent with the previous year[49] Interest and Receivables - Interest expenses for the six months ended June 30, 2020, rose to HKD 9,968,000, up from HKD 8,245,000 in the same period of 2019, marking an increase of 21%[47] - Trade receivables decreased to HKD 212,000 as of June 30, 2020, from HKD 871,000 as of December 31, 2019[52] - The company’s trade payables decreased to HKD 3,562,000 as of June 30, 2020, down from HKD 5,676,000 as of December 31, 2019[52] - The company’s borrowings increased to HKD 218,984,000 as of June 30, 2020, compared to HKD 207,052,000 as of December 31, 2019[52]

Financial Performance - The company recorded revenue of HKD 40.2 million for the year ended December 31, 2019, a decrease of 30.0% from HKD 58.2 million in 2018[5]. - Gross profit was HKD 23.3 million, with a gross margin of 58.0%, compared to HKD 30.9 million and a gross margin of 53.0% in 2018[5]. - The consolidated loss attributable to the company was HKD 77.0 million, an increase of 16.4% from HKD 66.1 million in 2018[5]. - The company reported a net loss attributable to owners of approximately HKD 77.0 million for the year ended December 31, 2019[108]. - Total revenue for the year was HKD 40.2 million, a decrease of 30.9% from HKD 58.2 million in 2018[114]. - Gross profit for the year was HKD 23.3 million, down 24.5% from HKD 30.9 million in the previous year[114]. - The company incurred an operating loss before tax of HKD 79.2 million, compared to a loss of HKD 64.8 million in 2018, reflecting a worsening financial position[114]. - The basic and diluted loss per share for the year was HKD 23.6, compared to HKD 20.3 in the previous year[114]. - Other comprehensive expenses for the year totaled HKD 89.6 million, significantly higher than HKD 3.2 million in 2018[114]. - The company recognized impairment losses on goodwill amounting to HKD 7.8 million during the year[114]. Assets and Liabilities - Total assets and net liabilities as of December 31, 2019, were HKD 41.7 million and HKD 263.8 million, respectively, compared to HKD 191.1 million and HKD 93.9 million in 2018[6]. - The company's current liabilities and total liabilities were HKD 172.9 million and HKD 263.8 million, respectively, as of December 31, 2019[108]. - Total assets decreased from HKD 191,177,000 in 2018 to HKD 41,711,000 in 2019, a decline of approximately 78.2%[116]. - Current liabilities increased from HKD 184,725,000 in 2018 to HKD 198,169,000 in 2019, an increase of about 7.3%[116]. - Total liabilities increased from HKD 184,725,000 in 2018 to HKD 263,833,000 in 2019, an increase of about 42.7%[116]. - The company's equity attributable to owners decreased from HKD (73,648,000) in 2018 to HKD (240,229,000) in 2019, indicating a worsening financial position[119]. - The company had a negative net asset value of HKD (263,833,000) in 2019 compared to HKD (93,892,000) in 2018, reflecting a significant deterioration in financial health[116]. Cash Flow and Liquidity - The company had a cash and bank balance of HKD 3.3 million, down from HKD 11.4 million in 2018[6]. - Cash and cash equivalents at year-end were only HKD 3.4 million, indicating insufficient liquidity to cover short-term borrowings of HKD 129.7 million[108]. - The net cash outflow from operating activities was HKD 16.1 million, an improvement from HKD 20.7 million in 2018[6]. - The net cash used in operating activities was HKD 16,187,000 for 2019, an improvement from HKD 20,684,000 in 2018, reflecting a decrease of approximately 22%[121]. - Cash and cash equivalents decreased to HKD 3,355,000 at the end of 2019 from HKD 11,429,000 at the beginning of the year, a decline of about 71%[121]. - The company generated net cash from investing activities of HKD 992,000 in 2019, down from HKD 4,540,000 in 2018, representing a decrease of approximately 78%[121]. - The company’s cash flow from financing activities showed a net inflow of HKD 7,121,000 in 2019, compared to a net outflow of HKD 8,634,000 in 2018, indicating a turnaround[121]. Corporate Governance - The board of directors includes independent non-executive directors who confirmed their independence according to the listing rules[42]. - The company has adopted a dividend policy that allows for distribution through cash or shares, but no dividends were recommended for the year ending December 31, 2019[34]. - The board of directors consists of five members with diverse skills and experiences in business, law, finance, accounting, and management[65]. - The audit committee, composed entirely of independent non-executive directors, reviewed the financial statements and internal control procedures for the year ending December 31, 2019[58]. - The company confirmed compliance with relevant laws and regulations, with no significant non-compliance issues identified during the year ending December 31, 2019[60]. - The company has complied with all corporate governance code provisions, except for the non-executive directors not having a specified term[64]. - Continuous professional development for directors is recognized as important to ensure informed contributions to the board[69]. - The company has a clear division of responsibilities between the chairman and the CEO to ensure a balance of power[66]. Risk Management - The company has faced significant risks including competition, credit risk, and foreign exchange risk, which may impact its financial performance[12][15][16]. - The company has established a risk management committee in April 2023 to monitor and manage risks faced by the group[77]. - The company has implemented measures to reduce energy consumption and waste generation, promoting resource efficiency and environmental responsibility[88]. - The company is aware of climate change impacts, such as typhoons and heavy rain, and has established procedures to ensure employee safety and property protection during extreme weather events[90]. Employee and Community Engagement - The company is committed to building mutually beneficial relationships with stakeholders, including employees, customers, suppliers, and the community[92]. - Employee health and well-being are considered critical for business success, with measures taken to protect employees during the COVID-19 pandemic[94]. - The company provides comprehensive on-the-job training programs and encourages participation in external seminars to enhance employee capabilities[95]. - Charitable donations for the year ending December 31, 2019, amounted to HKD 18,000, a decrease from HKD 147,000 in 2018[35]. - Charitable contributions made by the company during the year amounted to HKD 18,000, reflecting its commitment to social responsibility[100]. Business Operations - The company’s main business is investment holding, with performance analysis provided in the consolidated financial statements[29]. - The company is primarily engaged in the distribution of medical equipment and products, indicating a focus on the healthcare sector[122]. - The company is actively seeking business opportunities to enhance long-term shareholder value despite challenges from the COVID-19 pandemic and other global issues[18]. - The company plans to continue strict financial management and seek new business opportunities for profit growth[18]. Accounting and Financial Reporting - The financial statements were prepared based on incomplete records, leading to non-compliance with Hong Kong Financial Reporting Standards[106]. - The financial statements are prepared based on historical cost, except for certain financial instruments measured at fair value[129]. - The financial statements are presented in Hong Kong dollars (HKD), which is also the functional currency of the company[134]. - The application of revised accounting standards is not expected to have a significant impact on the group's financial position or performance[127]. - Related party transactions are disclosed in accordance with the relevant accounting standards[183].

Financial Performance - The group recorded revenue of HKD 23.9 million for the six months ended June 30, 2019, down from HKD 26.5 million in 2018, representing a decrease of approximately 9.8%[5] - Gross profit was HKD 12.6 million, with a gross margin of 52.8%, slightly down from HKD 14.0 million and 52.9% in 2018[5] - The group reported a consolidated loss of HKD 25.0 million, an improvement from a loss of HKD 40.4 million in the same period of 2018[5] - For the six months ended June 30, 2019, the company's revenue was HKD 23,911,000, a decrease of 9.5% compared to HKD 26,520,000 in the same period of 2018[27] - The gross profit for the same period was HKD 12,617,000, down 10.1% from HKD 14,025,000 year-on-year[27] - The company reported a loss before tax of HKD 24,974,000, an improvement from a loss of HKD 40,391,000 in the previous year, representing a 38.1% reduction in losses[27] - The total comprehensive loss for the period was HKD 25,406,000, compared to HKD 37,288,000 in the same period last year, indicating a 31.8% decrease[27] - The company reported a net loss attributable to owners of HKD 98,831,000 for the six months ended June 30, 2019, compared to a loss of HKD 73,648,000 for the same period in 2018, representing an increase in loss of approximately 34%[32] - The company reported a total loss before tax of HKD 24.974 million for the six months ended June 30, 2019[43] - The company reported a loss of HKD 24,751,000 for the six months ended June 30, 2019, compared to a loss of HKD 40,126,000 in the same period of 2018, representing a 38.3% improvement in losses year-over-year[50] Assets and Liabilities - Total assets and net liabilities as of June 30, 2019, were HKD 178.3 million and HKD 118.1 million, respectively, compared to HKD 191.2 million and HKD 93.9 million at the end of 2018[6] - Cash and bank balances decreased to HKD 3.2 million from HKD 11.4 million at the end of 2018, with a current ratio of 0.6, down from 0.7[6] - The group’s total borrowings increased to HKD 229.9 million from HKD 217.5 million at the end of 2018[6] - The company’s total assets as of June 30, 2019, were HKD 178.263 million, with total liabilities at HKD 296.361 million[44] - The company’s total liabilities increased from HKD 184,725,000 in December 2018 to HKD 194,843,000 in June 2019, indicating a rise of approximately 5.5%[30] - The company’s total equity attributable to owners decreased from HKD (73,648,000) in December 2018 to HKD (98,831,000) in June 2019, indicating a decline of approximately 34%[32] Cash Flow - The net cash outflow from operating activities was HKD 13.0 million, an improvement from HKD 22.6 million in 2018[6] - The net cash used in operating activities was HKD 13,039,000 for the six months ended June 30, 2019, an improvement from HKD 22,625,000 in the same period of 2018[35] - The company reported a net cash used in investing activities of HKD 18,000 for the six months ended June 30, 2019, compared to HKD 331,000 in the same period of 2018[35] - The company’s financing activities generated a net cash inflow of HKD 4,810,000 for the six months ended June 30, 2019, contrasting with a cash outflow of HKD 2,056,000 in the same period of 2018[35] Business Operations - The company is actively seeking new business opportunities to enhance long-term shareholder value despite challenges from external factors[7] - There were no significant investments or acquisitions during the reporting period[9] - The company is actively developing its medical and health business to improve cash flow[40] - The company is seeking to implement a restructuring plan to improve its financial situation[40] Corporate Governance - The company has complied with the corporate governance code as per the listing rules, except for the non-executive directors not having a specified term[25] - The audit committee reviewed the interim results for the six months ended June 30, 2019, ensuring the integrity of financial reporting[26] - The company did not declare an interim dividend for the six months ended June 30, 2019, consistent with the previous year[49] Employee and Operational Costs - Employee salaries and benefits significantly decreased to HKD 14,956,000 in 2019 from HKD 29,474,000 in 2018, a reduction of 49.3%[48] - Total depreciation expenses decreased to HKD 1,397,000 in 2019 from HKD 1,547,000 in 2018, reflecting a reduction of 9.7%[48] Share Capital and Options - The company did not grant any share options or share awards during the six months ended June 30, 2019[21][22] - The company has adopted a share option scheme to incentivize eligible participants, which has not resulted in any options being granted in the reporting period[21] - The company held 20,452,570 shares under the share award plan as of June 30, 2019[22] - The average number of ordinary shares used for calculating basic and diluted loss per share remained unchanged at 326,037,000 shares[50] - The company’s total issued and paid-up capital remained at HKD 3,030,660,000 with 326,037,000 shares as of both December 31, 2018, and June 30, 2019[54]

Financial Performance - The company recorded revenue of HKD 58.2 million for the year ended December 31, 2018, a decrease of 51.7% from HKD 120.5 million in 2017[5]. - Gross profit was HKD 30.9 million, down from HKD 46.7 million in 2017, with a gross margin of 53.0%, an increase from 38.8% in the previous year[5]. - The consolidated loss attributable to the company was HKD 66.1 million, significantly reduced from HKD 228.6 million in 2017[5]. - Revenue for the year 2018 was HKD 58,229,000, a decrease of 51.7% compared to HKD 120,522,000 in 2017[119]. - Gross profit for 2018 was HKD 30,857,000, down 34.0% from HKD 46,714,000 in 2017[119]. - The loss before tax for 2018 was HKD 64,772,000, an improvement from a loss of HKD 222,235,000 in 2017[119]. - The total comprehensive loss for the year was HKD 67,843,000, compared to HKD 229,135,000 in 2017, indicating a significant reduction in losses[120]. - Basic and diluted loss per share for continuing operations was HKD 20.3 cents, improved from HKD 63.8 cents in 2017[120]. - The company reported a significant reduction in administrative expenses to HKD 77,722,000 in 2018 from HKD 113,873,000 in 2017, reflecting cost-cutting measures[119]. - The company reported a loss of HKD 64,772,000 for the year ended December 31, 2018, compared to a loss of HKD 222,235,000 in 2017, indicating a significant improvement[127]. Assets and Liabilities - Total assets and net liabilities as of December 31, 2018, were HKD 191.1 million and HKD 93.9 million, respectively, compared to HKD 311.3 million and HKD 28.5 million in 2017[6]. - The company had a cash and bank balance of HKD 11.4 million, down from HKD 36.2 million in 2017, with a current ratio of 0.7 compared to 0.9 in the previous year[6]. - The total borrowings amounted to HKD 217.5 million, a decrease from HKD 292.5 million in 2017, including bank loans of HKD 198.1 million[6]. - As of December 31, 2018, the group's current liabilities and total liabilities were HKD 106.1 million and HKD 93.9 million, respectively, including borrowings of HKD 123.1 million due within one year[113]. - The group's cash and cash equivalents balance was HKD 11.4 million, indicating insufficient liquidity to repay borrowings[113]. - The total equity attributable to the owners of the company showed a loss of HKD 73,648,000 in 2018, compared to a loss of HKD 5,894,000 in 2017[123]. Governance and Management - The board of directors includes independent non-executive directors who have confirmed their independence according to the listing rules[42]. - The company’s board of directors consists of experienced professionals with backgrounds in law, finance, and business development[41]. - The audit committee, composed entirely of independent non-executive directors, reviewed the group's financial statements for the year ended December 31, 2018, and found no disagreements with the auditors regarding accounting policies[62]. - The company has maintained compliance with all corporate governance codes and regulations, with no known significant non-compliance issues affecting its operations as of December 31, 2018[65]. - The board recognizes the importance of continuous professional development for directors, ensuring they remain informed and capable of making relevant contributions[74]. - The company has established four committees under the board, including the audit committee, to oversee various aspects of its operations[77]. Risk Management - The company has faced significant risks including competition, credit risk, and foreign exchange risk, which it is actively managing[12][15][16]. - The company has established a Risk Management Committee in April 2023, consisting of three members, to monitor and assess risks faced by the group[82]. Environmental and Social Responsibility - The company is committed to reducing environmental impact and has implemented measures to improve energy efficiency and reduce waste[93]. - The group has not encountered any significant environmental or social risks from its suppliers and will continue to evaluate supplier performance regularly[101]. - The group has a zero-tolerance policy towards child labor and forced labor, ensuring all potential candidates provide identification for verification[98]. - The group encourages employees to report misconduct through confidential channels, maintaining a culture of integrity and compliance with anti-corruption laws[104]. - The group made charitable donations amounting to HKD 147,000 during the year, demonstrating its commitment to social responsibility[105]. Financial Reporting and Compliance - The company’s financial performance and position are discussed in the management discussion and analysis section of the report[34]. - The financial statements are prepared based on historical cost, except for certain financial instruments measured at fair value[137]. - The company has confirmed assets and related finance lease liabilities for its financing lease arrangements as a lessee under HKAS 17, which may lead to potential changes in asset classification under HKFRS 16[133]. - The independent auditor's report highlighted the inability to quantify necessary adjustments to the financial statements due to incomplete records[112]. - The group failed to comply with Hong Kong Financial Reporting Standards, resulting in incomplete financial statements[112]. Future Outlook and Strategy - The company is actively seeking business opportunities to enhance long-term shareholder value despite challenges from the COVID-19 pandemic and other geopolitical factors[18]. - The company plans to continue strict financial management and seek new business opportunities to achieve profit growth and improve stakeholder value[18]. - The company is seeking to implement a restructuring plan to improve its financial situation[143]. - The board believes that the group will have sufficient working capital to meet its financial obligations within the next twelve months[140].

Financial Performance - The company recorded revenue of HKD 26.5 million for the six months ended June 30, 2018, a decrease from HKD 83.7 million in 2017, with a gross profit of HKD 14.0 million and a gross margin of 52.9%[5] - The consolidated loss attributable to the company was HKD 40.4 million, compared to HKD 136.4 million in 2017, indicating an improvement in financial performance[5] - Revenue for the six months ended June 30, 2018, was HKD 26,520,000, a decrease of 68.3% compared to HKD 83,726,000 in 2017[27] - Gross profit for the same period was HKD 14,025,000, down 49.5% from HKD 27,737,000 in 2017[27] - The loss before tax for continuing operations was HKD 40,391,000, significantly improved from a loss of HKD 115,564,000 in the previous year[27] - The total comprehensive loss for the period was HKD 37,288,000, compared to HKD 119,450,000 in 2017, indicating a reduction of 68.9%[28] - Basic and diluted loss per share for continuing operations was HKD 12.3 cents, down from HKD 34.9 cents in the previous year[28] - The net loss attributable to owners of the company for the period was HKD 42,917,000, compared to HKD 5,894,000 in the previous year[30] - The company reported a net loss of HKD 40,400,000 for the six months ended June 30, 2018, compared to a loss of HKD 134,177,000 in the previous period[39] - The group incurred a total loss of HKD 40,391,000 for the six months ended June 30, 2018, compared to a loss of HKD 136,375,000 for the same period in 2017[44][53] Assets and Liabilities - As of June 30, 2018, the total assets and net liabilities of the group were HKD 290.3 million and HKD 65.8 million, respectively, with cash and bank balances of HKD 11.2 million[6] - Non-current assets totaled HKD 199,255,000 as of June 30, 2018, slightly decreased from HKD 200,147,000 at the end of 2017[30] - Current liabilities increased to HKD 256,302,000 from HKD 241,557,000, reflecting a rise of 6.1%[30] - The company’s total liabilities as of June 30, 2018, included a net current liability of HKD 165,200,000 and a net liability of HKD 65,800,000[39] - The group’s total liabilities increased to HKD 356,100,000 as of June 30, 2018, compared to HKD 128,368,000 as of December 31, 2017[46][56] Cash Flow - The group reported a net cash outflow of HKD 25.0 million for the six months ended June 30, 2018, compared to a net inflow of HKD 10.5 million in 2017[6] - Cash and cash equivalents decreased to HKD 11,195,000 from HKD 36,207,000, a decline of 69.0%[30] - The company experienced a net cash outflow from operating activities of HKD 22,625,000, an improvement from HKD 27,583,000 in the previous year[34] - The company’s cash flow from financing activities showed a net outflow of HKD 2,056,000, contrasting with a net inflow of HKD 41,368,000 in the previous year[34] Business Operations - The company has been actively seeking business opportunities to enhance long-term shareholder value despite challenges from the COVID-19 pandemic and other global economic factors[7] - The company aims to continue seeking new business opportunities to achieve profit growth and enhance long-term stakeholder value[7] - The company has not conducted any capital raising activities during the six months ended June 30, 2018[8] - There were no significant investments or acquisitions during the reporting period[9] - The company has terminated the consolidation of its subsidiary responsible for sports and health clubs due to loss of control, impacting its financial reporting[38] Corporate Governance - The company confirmed compliance with the corporate governance code during the six months ended June 30, 2018, except for the lack of a specified term for non-executive directors[25] - The audit committee reviewed the group's interim performance for the six months ended June 30, 2018[26] Shareholder Information - No shares were purchased, sold, or redeemed by the company or its subsidiaries during the six months ended June 30, 2018[19] - The company did not grant any stock options during the six months ended June 30, 2018, and the total number of unexercised options as of June 30, 2018, was 29,669,346[21] - The company held 20,452,570 shares under the share award scheme as of June 30, 2018, with no awards granted during the reporting period[22] - As of June 30, 2018, the number of issued and fully paid shares is 326,037 thousand shares, amounting to HKD 3,030,660 thousand[58] - The group did not declare an interim dividend for the six months ended June 30, 2018[51] Loans and Financing - The group secured a loan of HKD 8,000,000 and another loan of HKD 12,000,000 to support its operational costs and business funding[44] - The total amount of bonds payable is HKD 20,000,000, with an interest rate ranging from 5% to 6.5%[57] - The group reported a decrease in interest expenses from HKD 16,601,000 in 2017 to HKD 10,656,000 in 2018[50] Employee Compensation - The group’s employee salaries and benefits amounted to HKD 29,474,000 for the six months ended June 30, 2018, compared to HKD 34,271,000 in 2017[50] Other Financial Metrics - The company reported a significant increase in other receivables, which rose to HKD 12,426,000 from HKD 8,776,000, an increase of 41.8%[30] - The group’s trade receivables were HKD 1,797,000 as of June 30, 2018, down from HKD 1,936,000 as of December 31, 2017[54] - The group’s total assets were HKD 290,337,000 as of June 30, 2018, compared to HKD 311,327,000 as of December 31, 2017[46][47] Legal Matters - A creditor filed for liquidation against the company in April 2023, claiming an unpaid debt of HKD 16,175,304, including interest and related costs[60]

Financial Performance - The company recorded revenue of HKD 120.5 million for the year ended December 31, 2017, representing a 18.5% increase from HKD 101.8 million in 2016[5]. - Gross profit for the same period was HKD 46.7 million, with a gross margin of 38.8%, up from HKD 35.3 million and a gross margin of 34.7% in 2016[5]. - The consolidated loss attributable to the company was HKD 228.6 million, a significant reduction from HKD 311.4 million in 2016[5]. - The loss before tax decreased to HKD 222,235,000 in 2017 from HKD 340,276,000 in 2016, representing a 34.7% improvement[119]. - The total comprehensive loss for the year was HKD 229,135,000, a reduction from HKD 412,028,000 in 2016, indicating a 44.3% decrease[121]. - The company reported a loss attributable to owners of the company of HKD 228,594,000 for 2017, compared to HKD 311,388,000 in 2016, reflecting a 26.6% improvement[121]. - The company reported a significant loss in fair value changes of financial assets amounting to HKD 189,046,000 in 2017, compared to HKD 41,804,000 in 2016[119]. - The company reported a net loss attributable to owners of approximately HKD 228.6 million for the year ended December 31, 2017[114]. Assets and Liabilities - As of December 31, 2017, the total assets and net liabilities of the group were HKD 311.3 million and HKD 28.5 million, respectively, compared to HKD 874.1 million and HKD 319.9 million in 2016[6]. - The company had cash and cash equivalents of HKD 36.2 million as of December 31, 2017, insufficient to cover its short-term borrowings[114]. - As of December 31, 2017, the company's current liabilities amounted to HKD 130.4 million, including borrowings of HKD 200.3 million due within one year[114]. - Non-current assets decreased significantly from HKD 484,434,000 in 2016 to HKD 200,147,000 in 2017, a decline of 58.7%[124]. - Current liabilities decreased from HKD 353,328,000 in 2016 to HKD 241,557,000 in 2017, a reduction of 31.6%[124]. - The company’s equity attributable to owners decreased to HKD (5,894,000) as of December 31, 2017, from HKD 245,877,000 at the beginning of the year[125]. Cash Flow - The net cash outflow from operating activities was HKD 54.5 million, an improvement from HKD 96.5 million in 2016, while net cash inflow from investing activities was HKD 99.3 million[6]. - Cash used in operating activities was HKD 54,058,000, a decrease from HKD 95,635,000 in the previous year, reflecting a 43.4% reduction in cash outflow[127]. - The company reported a decrease in cash and cash equivalents at year-end to HKD 36,207,000 from HKD 72,943,000 at the beginning of the year, reflecting a net decrease of HKD 33,409,000[128]. - The total cash outflow from financing activities was HKD 78,151,000, contrasting with a cash inflow of HKD 147,170,000 in the previous year[128]. Business Operations and Strategy - The company has been actively seeking business opportunities to enhance long-term shareholder value despite limited resources due to prolonged trading suspension and heavy debts[19]. - The medical equipment and product distribution business has shown good progress in 2022 and 2023, despite challenges from the US-China trade conflict and the COVID-19 pandemic[19]. - The company is confident that its business will continue to thrive in 2023 and beyond as the global, Hong Kong, and Chinese economies gradually open up[19]. - The company aims to achieve profit growth and enhance long-term stakeholder value by adopting new policies and ensuring prudent financial and cash flow management[19]. - The company continues to face challenges from adverse global economic factors that may impact its operations[19]. Corporate Governance - The board of directors consists of five members with diverse skills and experience in business, law, finance, accounting, and management[70]. - The audit committee is composed entirely of independent non-executive directors and is responsible for reviewing the company's annual, interim, and quarterly financial reports[63]. - The company has complied with all code provisions of the corporate governance code, except for the non-executive directors not having a specified term[69]. - The company has established four committees under the board, including the audit committee, remuneration committee, nomination committee, and risk management committee[77]. - The remuneration committee has reviewed the remuneration of directors and senior management, finding it to be fair and reasonable[79]. Risk Management - The board has acknowledged various risks, including credit, currency, and interest rate risks, and has implemented management policies to mitigate these risks[12][15][16][17]. - The company is committed to maintaining a robust risk management system to ensure effective operations and compliance with applicable laws[86]. - The company has established a Risk Management Committee in April 2023, consisting of three members, to monitor and manage risks effectively[82]. Environmental and Social Responsibility - The company has implemented measures to minimize environmental impact, including promoting recycling and energy efficiency[93]. - The company does not generate significant harmful emissions, primarily producing non-hazardous waste, and adheres to relevant environmental regulations[92]. - The company encourages employees to participate in volunteer services and charitable work, contributing to the community[105]. - The company has a zero-tolerance policy towards child labor and forced labor, requiring all potential candidates to provide identification for verification[98]. Shareholder Information - The company did not engage in any capital raising activities during the year ended December 31, 2017[8]. - The board of directors has adopted a dividend policy aimed at ensuring continuity, stability, and sustainability, but no dividends were recommended for the year ended December 31, 2017[36]. - The company has issued at least 25% of its total issued share capital to the public as of the report date[66]. Accounting and Financial Reporting - The financial statements are prepared based on historical cost, except for certain financial instruments measured at fair value[148]. - The company failed to comply with Hong Kong Financial Reporting Standards due to incomplete accounting records[113]. - The company has not provided adequate audit evidence to confirm the accuracy of its consolidated financial statements for the year ended December 31, 2017[110]. - The application of HKFRS 15 resulted in a reclassification of HKD 60,808,000 from deferred income to contract liabilities, impacting the financial position[134]. - The company adopted HKFRS 9, which led to a reclassification of financial assets, increasing the fair value of financial assets at fair value through profit or loss to HKD 215,809,000[137].

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責， 對其準確性或完整性亦不發表任何聲明，並明確表示概不就本公告全部或任何部分 內容而產生或因倚賴該等內容而引致之任何損失承擔任何責任。 京玖醫療健康有限公司 648 二零二二年末期業績 京玖醫療健康有限公司（「本公司」）董事會（「董事會」）現呈報本公司及其附屬公司（「本 集團」）截至二零二二年十二月三十一日止年度之經審核綜合末期業績。 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責， 對其準確性或完整性亦不發表任何聲明，並明確表示概不就本公告全部或任何部分 內容而產生或因倚賴該等內容而引致之任何損失承擔任何責任。 京玖醫療健康有限公司 648 二零二一年末期業績 京玖醫療健康有限公司（「本公司」）董事會（「董事會」）現呈報本公司及其附屬公司（「本 集團」）截至二零二一年十二月三十一日止年度之經審核綜合末期業績。 ...